Summit Trail Advisors LLC Acquires 319 Shares of CME Group Inc. (NASDAQ:CME)

Summit Trail Advisors LLC grew its holdings in shares of CME Group Inc. (NASDAQ:CME) by 9.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,608 shares of the financial services provider’s stock after acquiring an additional 319 shares during the quarter. Summit Trail Advisors LLC’s holdings in CME Group were worth $796,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CME. Wealth Enhancement Advisory Services LLC raised its position in CME Group by 21.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after purchasing an additional 8,443 shares during the last quarter. Cetera Investment Advisers raised its holdings in CME Group by 429.1% in the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after buying an additional 38,540 shares during the last quarter. Brookstone Capital Management boosted its position in CME Group by 12.2% during the 2nd quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock worth $6,156,000 after buying an additional 3,325 shares during the period. Mather Group LLC. grew its holdings in CME Group by 197.2% during the 2nd quarter. Mather Group LLC. now owns 6,066 shares of the financial services provider’s stock worth $1,306,000 after acquiring an additional 4,025 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. increased its position in CME Group by 40.8% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 10,742 shares of the financial services provider’s stock valued at $2,112,000 after acquiring an additional 3,112 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 12.01 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares of the company’s stock, valued at $6,131,291.92. This represents a 14.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock valued at $3,441,063 over the last ninety days. 0.30% of the stock is owned by company insiders.

CME Group Trading Up 0.1 %

NASDAQ:CME opened at $229.37 on Tuesday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.74. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a market capitalization of $82.66 billion, a price-to-earnings ratio of 24.12, a PEG ratio of 5.28 and a beta of 0.55. The firm has a fifty day simple moving average of $223.86 and a two-hundred day simple moving average of $211.19.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the business posted $2.25 EPS. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. Analysts expect that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.01%. CME Group’s dividend payout ratio is 48.37%.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent research reports. Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Barclays lifted their target price on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a report on Thursday, October 24th. Morgan Stanley increased their price target on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Deutsche Bank Aktiengesellschaft cut their price objective on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Bank of America raised their price target on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, CME Group currently has a consensus rating of “Hold” and an average price target of $224.47.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.